Over the last years, cell culture is increasingly often used for industrial purpose especially in the area of drug development and testing und GLP and GMP. This leads to the positive effect, that for the first time, new methods are developed in quick succession and old difficulties are challenged.

Cell cultures are now used to produce peptides and protein drugs in bioreactors such as:

• Insulin, transferrin, interferons
• Medical and analytical antibodies and
• vaccines as well as other drugs

in bioreactors. Besides the use in research labs, 

• Bio-Assays,
• 3D-models or
• tissue-engineering approaches

have become important methods in industrial production and quality controls labs. In the area of bioassays, cell cultures are now inexpendible for cell-based release assays such as potency, content and toxicity of active pharmaceutical ingredients (API) and finished drug products. 

Primary cells are used as a replacement for animal models and tests. Somatic cells and adults stem cells now become drugs themselves as

• Somatic cell therapeutics
• TEP (tissue engineering products, 3D-cultures and non-homologous use of stem cells),
• ATMP (advanced therapy medicinal products, e.g. bone marrow or adipose-derived stem cells),
• Gene therapeutics (with or without living cells)

Even though some advancements are expensive, many other of these new developments are scalable, suitable and affordable for academic and small business use as well. Use our pages to get up dates on new products such as modern incubators, cell culture plastic ware, mycoplasma test kits, cell counters and others. Our training courses convey comprehensive overviews over cell culture, standardization or bioassay reproducibility.